• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tissue inactivation of slow reacting substance of anaphylaxis.过敏反应迟缓反应物质的组织失活
Immunology. 1976 Jan;30(1):83-7.
2
Slow reacting substance as a preformed mediator from human lung.慢反应物质作为人肺中一种预先形成的介质。
Immunology. 1976 Nov;31(5):813-20.
3
Non-immunological release of slow-reacting substance from guinea-pig lungs.豚鼠肺中慢反应物质的非免疫性释放。
Br J Pharmacol. 1979 Sep;67(1):67-72.
4
Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases.芳基硫酸酯酶对过敏反应慢反应物质(SRS-A)的灭活作用。
J Immunol. 1974 Jul;113(1):316-22.
5
Computerization of a bioassay: quantitation of slow reacting substance of anaphylaxis (SRS-A).生物测定的计算机化:过敏反应慢反应物质(SRS-A)的定量分析
J Pharmacol Exp Ther. 1979 May;209(2):238-43.
6
Separation of slow reacting substance of anaphylaxis (SRS-A) from human lung into four biologically active fractions.将人肺中的过敏反应慢反应物质(SRS-A)分离成四个生物活性组分。
J Immunol. 1976 Sep;117(3):1039-44.
7
Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis.人肺芳基硫酸酯酶B。分离、特性鉴定及其与过敏反应迟缓反应物质的相互作用。
J Clin Invest. 1976 Mar;57(3):738-44. doi: 10.1172/JCI108332.
8
Regulation of the synthesis and release of slow-reacting substance of anaphylaxis from sensitized monkey lung.致敏猴肺中过敏反应慢反应物质合成与释放的调节
J Pharmacol Exp Ther. 1982 May;221(2):295-302.
9
Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase.人嗜酸性粒细胞芳基硫酸酯酶对过敏反应迟缓反应物质的灭活作用
J Immunol. 1975 Feb;114(2 Pt 1):645-9.
10
Relative bioactivity of histamine and slow reacting substance of anaphylaxis released during anaphylactic reaction from different tissues of guinea pigs and rats.豚鼠和大鼠不同组织在过敏反应期间释放的组胺和过敏反应迟缓反应物质的相对生物活性。
Indian J Physiol Pharmacol. 1987 Apr-Jun;31(2):107-10.

引用本文的文献

1
Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.药物对豚鼠抗原诱导的爪肿胀的调节作用:脂多糖、肿瘤坏死因子和白细胞耗竭的影响。
Br J Pharmacol. 1994 May;112(1):111-6. doi: 10.1111/j.1476-5381.1994.tb13038.x.
2
Characterization of slow reacting substances (SRSs) of rat basophilic leukemia (RBL-1) cells: effect of cysteine on SRS profile.大鼠嗜碱性白血病(RBL-1)细胞慢反应物质(SRSs)的特性:半胱氨酸对SRS图谱的影响。
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6481-5. doi: 10.1073/pnas.77.11.6481.
3
Identification of the slow reacting substances from cat paws.猫爪中慢反应物质的鉴定。
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5688-92. doi: 10.1073/pnas.77.10.5688.

本文引用的文献

1
SULFUR METABOLISM OF AEROBACTER AEROGENES. I. A REPRESSIBLE SULFATASE.产气气杆菌的硫代谢。I. 一种可阻遏的硫酸酯酶。
Biochemistry. 1964 Feb;3:224-30. doi: 10.1021/bi00890a014.
2
Slow reacting substance and related compounds.慢反应物质及相关化合物。
Prog Allergy. 1962;6:539-58.
3
The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.过敏性休克期间组胺的释放及慢反应物质(SRS-A)的形成。
J Physiol. 1960 Jun;151(3):416-35. doi: 10.1113/jphysiol.1960.sp006449.
4
The sulphatase of ox liver. 7. The intracellular distribution of sulphatases A and B.牛肝硫酸酯酶。7. 硫酸酯酶A和B的细胞内分布。
Biochem J. 1960 Nov;77(2):380-6. doi: 10.1042/bj0770380.
5
Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.嗜酸性白细胞迁移的研究。II. 抗原抗体复合物从豚鼠血清中产生的对嗜酸性粒细胞和中性粒细胞具有特异性趋化作用的因子。
Clin Exp Immunol. 1970 Nov;7(5):723-37.
6
Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases.芳基硫酸酯酶对过敏反应慢反应物质(SRS-A)的灭活作用。
J Immunol. 1974 Jul;113(1):316-22.
7
Formation of slow-reacting substance of anaphylaxis in human lung tissue and cells before release.人肺组织和细胞中过敏反应迟缓反应物质在释放前的形成。
J Exp Med. 1974 Nov 1;140(5):1133-46. doi: 10.1084/jem.140.5.1133.
8
An eosinophil leukocyte chemotactic factor of anaphylaxis.过敏反应的嗜酸性粒细胞趋化因子。
J Exp Med. 1971 Mar 1;133(3):602-19. doi: 10.1084/jem.133.3.602.
9
Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase.人嗜酸性粒细胞芳基硫酸酯酶对过敏反应迟缓反应物质的灭活作用
J Immunol. 1975 Feb;114(2 Pt 1):645-9.

过敏反应迟缓反应物质的组织失活

Tissue inactivation of slow reacting substance of anaphylaxis.

作者信息

Kay A B, Roberts E M, Jones D G

出版信息

Immunology. 1976 Jan;30(1):83-7.

PMID:1248864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1444951/
Abstract

The release of slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea-pig lung challenged with antigen was followed by a fall in the activity of this mediator in the diffusate when the incubations were continued for 3 h. The inactivating principle was also present in normal lung in addition to other normal guinea-pig tissues such as the liver, kidney, spleen, ileum and skin. No acitivity was found in muscle. Evidence is provided that some of this SRS-A-inactivating activity was due to tissue arylsulphatases. These were measured by hydrolysis of p-nitrophenyl sulphate (p-NPS) and p-nitrocatechol sulphate (p-NCS), which reflect activities of arylsulphatase II A and II B respectively. Hydrolytic activity for p-NCS was present in all tissues with SRS-A-inactivating properties, whereas only lung, liver and skin tissue hydrolysed p-NCS and p-NPS. Following passage of a cell-free lung homogenate through a column of Sephadex G-200 the p-NCS hydrolysing and SRS-Z-inactivating activities eluted together, with molecules having a molecular size of approximately 150,000 Daltons, p-NPS hydrolysing activity being destroyed during the preparation of the homogenate. The release of arylsulphatase from sensitized tissue was not dependent on the presence of specific antigen. These experiments suggest that inactivation of SRS-A is related to tissue arylsulphatase and that these enzymes may play a role in the expression of the effective levels of this mediator within the tissues.

摘要

用抗原攻击致敏豚鼠肺脏后,过敏反应慢反应物质(SRS-A)会释放出来。当孵育持续3小时时,扩散液中这种介质的活性会下降。除了肝脏、肾脏、脾脏、回肠和皮肤等其他正常豚鼠组织外,正常肺脏中也存在这种失活原理。在肌肉中未发现活性。有证据表明,部分SRS-A失活活性是由于组织芳基硫酸酯酶引起的。通过对硫酸对硝基苯酯(p-NPS)和硫酸对硝基儿茶酚(p-NCS)的水解来测量这些酶,它们分别反映芳基硫酸酯酶II A和II B的活性。具有SRS-A失活特性的所有组织中都存在对p-NCS的水解活性,而只有肺、肝脏和皮肤组织能水解p-NCS和p-NPS。将无细胞肺匀浆通过Sephadex G-200柱后,对p-NCS的水解活性和SRS-Z失活活性一起洗脱,分子大小约为150,000道尔顿,在匀浆制备过程中,对p-NPS的水解活性被破坏。致敏组织中芳基硫酸酯酶的释放不依赖于特异性抗原的存在。这些实验表明,SRS-A的失活与组织芳基硫酸酯酶有关,并且这些酶可能在该介质在组织内的有效水平表达中起作用。